CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

CHAPTER 4 U.S. AND EUROPE HEAD LICE INFESTATION DRUGS MARKET, BY TYPE

4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. LOTION
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast by region
4.2.3. Market analysis, by country
4.3. CREAMS
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast by region
4.3.3. Market analysis, by country
4.4. SHAMPOO
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast by region
4.4.3. Market analysis, by country
4.5. OTHERS
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast by region
4.5.3. Market analysis, by country

CHAPTER 5 U.S. AND EUROPE HEAD LICE INFESTATION DRUGS MARKET, BY REGION (VALUE AND VOLUME)

5.1. OVERVIEW
5.2. U.S.
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast (Value & Volume)
5.2.3. Pricing analysis
5.2.4. North America head lice infestation drugs market, by type
5.3. EUROPE
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast (Value & Volume)
5.3.3. Pricing analysis
5.3.4. Europe head lice infestation drugs market, by type
5.3.5. Europe head lice infestation drugs market, by country
5.3.5.1. Germany Head Lice Infestation Drugs market
5.3.5.1.1. Market size and forecast
5.3.5.2. France Head Lice Infestation Drugs market
5.3.5.2.1. Market size and forecast
5.3.5.3. UK Head Lice Infestation Drugs market
5.3.5.3.1. Market size and forecast
5.3.5.4. Italy Head Lice Infestation Drugs market
5.3.5.4.1. Market size and forecast
5.3.5.5. Spain Head Lice Infestation Drugs market
5.3.5.5.1. Market size and forecast
5.3.5.6. Rest of Europe Head Lice Infestation Drugs market
5.3.5.6.1. Market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1. BAYER
6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments
6.2. PRESTIGE BRANDS
6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments
6.3. RECKITT BENCKIER
6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments
6.4. SHIONOGI
6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments
6.5. TYRATECH
6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments
6.6. OMEGA PHARMA
6.6.1. Operating business segments
6.6.2. Business performance
6.6.3. Key strategic moves and developments
6.7. HATCHTECH
6.7.1. Operating business segments
6.7.2. Business performance
6.7.3. Key strategic moves and developments
6.8. MCCABES PHARMACY
6.8.1. Operating business segments
6.8.2. Business performance
6.8.3. Key strategic moves and developments
6.9. ARBOR PHARMACEUTICALS
6.9.1. Operating business segments
6.9.2. Business performance
6.9.3. Key strategic moves and developments